Bifogade filer
PDF
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Hørsholm, Denmark, April 7, 2022 - ExpreS2ion Biotech Holding AB's affiliate ExpreS2ion Biotechnologies ApS ("ExpreS2ion") will participate and hold presentations at key industry and investor events in the coming month. These include the World Vaccine Congress (April 18-21), a Q&A session covering the 2022 Rights Issue (April 25), Økonomisk Ugebrev Life Science Investor Conference (April 27), PEGS Summit (May 2-6), and the ESMO Breast Cancer Meeting (May 3-5).
By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS[2] technology platform and its exciting development pipeline, including the novel ES2B-C001 HER2-cVLP breast cancer vaccine. More information on each event and how to register is found below.
World Vaccine Congress, April 18-21
Washington, D.C., USA
Meet in-person with ExpreS[2]ion's CMO, Mattis Flyvholm Ranthe at the largest, most established meeting dedicated to vaccines. More information and registration can be found on the World Vaccine Congress website (https://www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm).
2022 Rights Issue Q&A hosted by H.C. Andersen Capital, April 25 at 11:00 CET
Virtual
ExpreS[2]ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2022 Rights Issue and answer investor's questions about how to participate. More information and registration can be found on the H.C. Andersen Capital events website (https://hcandersencapital.dk/events/) closer to the webcast.
Økonomisk Ugebrev Life Science Investor Conference, April 27 at 15:50-16:20 CET
Copenhagen, Denmark
See the company presentation by our CEO Bent U. Frandsen at this investor event. It is possible to attend the meeting by reserving a seat on the event website (https://www.eventbrite.co.uk/e/life-science-investor-konference-den-27-april-2022-tickets-296710217247?aff=odeimcmailchimp&utm_source=Marketing&utm_campaign=bb056e5d1f-EMAIL_CAMPAIGN_2019_08_20_07_22_COPY_01&utm_medium=email&utm_term=0_32a4ba3d31-bb056e5d1f-108505633&mc_cid=bb056e5d1f&mc_eid=f12ce3e69b).
PEGS Summit, May 2-6
Boston, MA, USA
Meet virtually with ExpreS[2]ion's VP of R&D and Technology, Max Søgaard, at the leading international meeting for the biotherapeutics community. More information and registration can be found on the PEGS Summit website (https://www.pegsummit.com/).
European Society for Medical Oncology (ESMO) Breast Cancer Meeting, May 3-5
Berlin, Germany and Virtual
Meet with ExpreS[2]ion's CMO, Mattis Flyvholm Ranthe, and VP of Preclinical Development, Mette Thorn, at 2022 ESMO Breast Cancer meeting. More information and registration can be found on the ESMO website (https://www.esmo.org/meetings/esmo-breast-cancer-2022).
Certified Adviser
Svensk Kapitalmarknadsgranskning AB
Telefon: +46 11 32 30 732
E-post: ca@skmg.se